5x broker valuation of 33c, page-70

This is all in my opinion. I believe that the company would have the in-house ability to have forecast the type of graphic result vs the Venus111 data they need to be achieving for a desired outcome.

This is a statement from the CEO in the 14 June trial update

“This month’s recruitment has been outstanding – and we’re delighted that the trial readout is now only a few months away. Having the results in hand means we will be able to accelerate discussions with potential partners while we finalise our next steps with the EU and US regulatory authorities.”

To me it seems a statement made with confidence.